COVID-19 symptom duration predicts immunoglobulin G seropositivity
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F21%3A10435514" target="_blank" >RIV/00216208:11110/21:10435514 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/21:N0000249 RIV/61989592:15110/21:73608302
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7EGVxC85fF" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7EGVxC85fF</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/BLL_2021_139" target="_blank" >10.4149/BLL_2021_139</a>
Alternative languages
Result language
angličtina
Original language name
COVID-19 symptom duration predicts immunoglobulin G seropositivity
Original language description
OBJECTIVES: The study focused on the relationship between routine clinical characteristics and anti-SARSCoV-2 specifi c antibodies in a pilot sample of healthcare workers (HCWs) having suffered COVID-19. The aim was to investigate the existence of readily available predictors of antibodies against COVID-19. METHODS: As part of the recognition of COVID-19 as an occupational disease in 152 HCWs with the mean age of 43.2 years, personal, anthropometric and anamnestic data related to the disease as well as anti-spike immunoglobulin (Ig) levels were obtained. Through descriptive statistics, correlation and regression analyses, relationships of all variables and Ig levels, especially seropositivity of IgG, were investigated. RESULTS: The mean interval between the symptom onset and the determination of antibodies was 58 days. IgG seropositivity and IgM seropositivity were noted in 82 % and 49 % of HCWs, respectively. Symptom duration was the only statistically signifi cant predictor of IgG seropositivity. With each day of symptom duration, the probability of IgG seropositivity increased from 1.078 to 1.092 times (p < 0.05). If symptoms lasted longer than 17 days, a majority (almost 80 %) of the subjects demonstrated seropositivity in the following months. CONCLUSION: The presence of IgG immunity may be assumed from symptom duration. Such easy recognizing of seropositive patients may be a useful tool, e.g. in vaccination strategies (Tab. 3, Fig. 1, Ref. 28). Text in PDF www.elis.sk
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10610 - Biophysics
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Bratislavské lekárske listy / Bratislava Medical Journal
ISSN
0006-9248
e-ISSN
—
Volume of the periodical
122
Issue of the periodical within the volume
12
Country of publishing house
SK - SLOVAKIA
Number of pages
5
Pages from-to
861-865
UT code for WoS article
000731753700004
EID of the result in the Scopus database
2-s2.0-85122558074